Ophthalmic naloxone elicits abstinence in opioid-dependent subjects.
Sanchez-Ramos
J R
JR
Senay
E C
EC
D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009270:Naloxone / Q000008:administration & dosage* / Q000009:adverse effects; D009883:Ophthalmic Solutions; D009293:Opioid-Related Disorders / Q000175:diagnosis* / Q000188:drug therapy; D011680:Pupil / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced*; D013997:Time Factors
D009883:Ophthalmic Solutions; D009270:Naloxone; D008691:Methadone